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Background: The objective of this study was to examine the effect of a mindfulness-based stress 
reduction (MBSR) program on women diagnosed with conditions such as multiple chemical 
sensitivity (MCS), chronic fatigue syndrome (CFS), and ﬁ  bromyalgia (FM).
Methods: The intervention group underwent a 10-week MBSR program. Symptoms Checklist 
Inventory (SCL-90R) was used as outcome measure and was administered before the start of 
the program (pre-), immediately upon completion (post-) and at three-month follow-up. Women 
on the wait list to receive treatment at the Nova Scotia Environmental Health Centre were used 
as control subjects for the study.
Results: A total of 50 participants in the intervention group and 26 in the wait-list controls 
group were recruited for this study. Global scores in the intervention group reached statistical 
signiﬁ  cance pre-post (0.0001) and at pre-follow-up (0.0001) while the global scores in 
the control group remained the same. Five of nine and eight of nine subscales of the SCL-90R 
showed improvement of statistical signiﬁ  cance in MBSR group following treatment and at 
three-month follow-up.
Conclusions: The study showed the importance of complementary interventions such as MBSR 
techniques in the reduction of psychological distress in women with chronic conditions.
Keywords: chronic conditions, multiple chemical sensitivity, mindfulness-based stress reduction, 
chemical sensitivity
Background
Conditions such as multiple chemical sensitivity (MCS), ﬁ  bromyalgia (FM), and 
chronic fatigue syndrome (CFS) are a signiﬁ  cant problem to the health care system due 
to the lack of effective management strategies.1–4 MCS is deﬁ  ned as a chronic condition 
with reproducible symptoms involving multiple organ systems whose symptoms are 
produced by low levels of exposure to multiple, chemically unrelated substances and 
improve or resolve when the chemical agents are removed.5 The Canadian Clinical 
Working Case deﬁ  nition for FM is that the condition is categorized by a history of 
widespread pain and pain on palpation at 11 or more of the deﬁ  ned tender point sites. 
Patients with this condition also experience signiﬁ  cant fatigue and cognitive problems.6 
A patient receives a diagnosis of CFS if they have severe chronic fatigue of six months 
or longer duration with other known medical conditions excluded by clinical diagnosis 
and they have concurrently four or more of the following symptoms: substantial impair-
ment in short-term memory or concentration; sore throat; tender lymph nodes; muscle 
pain; multi-joint pain without swelling or redness; headaches of a new type, pattern or 
severity; unrefreshing sleep; and post-exertional malaise lasting more than 24 hours.7 Journal of Multidisciplinary Healthcare 2009:2 54
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Aaron and Buchwald8 reviewed the shared features of MCS, 
CFS, and FM such as fatigue/pain, inconsistent demonstra-
tion of laboratory abnormalities, disability out of proportion 
to examination ﬁ  ndings, and association with “stress” and 
psychosocial factors. They found signiﬁ  cant overlap among 
deﬁ  nitions for the core symptoms of these conditions sug-
gesting co-morbidity of these conditions for patients.
MCS, FM, CFS, and in some cases chronic pain have been 
attributed to the environment. For these conditions there are no 
speciﬁ  c or standardized management strategies for treatment 
that have been shown to alleviate or reverse the condition.9–12 
The challenges in developing standardized care lie in the num-
ber of overlapping conditions with a wide variety of symptoms 
which are poorly characterized, but appear to be linked to the 
environment. Predominantly, patients require an individualized 
care plan that takes into account all aspects of their illness.9 
However, since these conditions are poorly understood with 
limited information in the literature and a multitude of over-
lapping symptoms and diagnoses, they often leave health care 
professionals challenged when attempting to develop a man-
agement strategy. These problems may be recognized by the 
patients, and this may lead to requests for referral to multiple 
specialists and the ordering of various costly laboratory tests.13 
Patients also learn to move beyond the traditional medical 
approach and begin to manage their own treatment.14,15
The Nova Scotia Environmental Health Centre (NSEHC) 
is a medical facility with a mandate for treatment and research 
of medical conditions such as MCS, CFS, and FM.16,17 At the 
NSEHC, a multidisciplinary approach to treatment is taken 
in which the various disciplines work together in generating 
information on all aspects of the patient’s illness before devel-
oping an individualized care plan for every patient. Research 
at the NSEHC is targeted towards understanding the nature 
of these illnesses, type and extent of symptom occurrence 
and their triggers, and the study of effective management 
strategies. Published research has added to our knowledge 
base of patients with MCS. Joffres and colleagues13 looked at 
the prevalence of major symptoms in 351 patients from the 
NSEHC. General symptoms such as difﬁ  culty concentrating, 
fatigue, forgetfulness, and irritability dominated the overall 
prevalence of symptoms since the start of their illness. Those 
related to irritation such as sneezing, itchy or burning eyes, and 
hoarseness or loss of voice were more common when exposed 
to environmental stressors. A review of 100 patients18 who 
fulﬁ  lled the consensus criteria for MCS5 has shown that major 
senses are frequently reported as being modiﬁ  ed, with 88% of 
patients reporting increased sense of smell, 74% reporting light 
sensitivity and 74% reporting sound sensitivity. Another study 
conducted at the NSEHC,19 investigated the ability to adapt 
to environmental challenges in individuals with and without 
MCS. Using a variety of physiological readings (skin con-
ductance, skin temperature, respiratory rate, surface electro-
myography, and heart rate) and from self-reported symptoms, 
we showed evidence that the majority of participants are in 
a heightened state of reactivity or central nervous system 
arousal and have altered sensitivity in the ﬁ  ve major senses. 
Subjects with chemical sensitivities took longer to adapt to 
baseline protocols such as variation in noise levels in the booth 
environment, than did controls. After adaptation (stability in 
physiological measures to baseline protocols), despite small 
study numbers, individuals with MCS displayed statistically 
signiﬁ  cant responses (  p  0.02) in tonic skin conductance 
response to test substances compared with controls and com-
pared with the control substance. Reported symptoms were 
also higher in cases than in controls for the test substances, 
body wash solution ( p = 0.05) and dryer sheets ( p = 0.02).
Clinical evaluations at the NSEHC have revealed that the 
patient population may have to cope with a variety of biopsy-
chosocial stressors in addition to the symptoms and stressors 
related to their illness. This additional stress may have a nega-
tive impact on their health and well being. Despite the concise 
deﬁ  nition for MCS,5 patients who receive this diagnosis often 
report being subjected to a variety of biases and misinterpreta-
tions from within the medical community, employers, family, 
and friends. Some of our patients report marginalization and 
negative labeling such as malingering or neurotic personality 
disorders.20 For patients who are desperate to feel well, and 
want to live as productive members of society in their work/
professions and interpersonal relationships, this adds another 
layer of stress of being misunderstood and viewed through 
the lens of a psychiatric disorder. In extreme cases, this may 
lead individuals to become fearful and skeptical of doctors, 
employers, insurance caseworkers, the justice system, and 
other agencies that become involved in an attempt to provide 
answers, solutions, and support to their state of illness and 
disease. While this may not be the only cause for the stress 
experienced by individuals with this diagnosis, it could add 
to the overall perception of stress in the management of their 
illness. The goal of the care management at the NSEHC is 
to address the whole person and offer interventions that can 
strengthen resiliency towards management of the illness and 
build coping skills to all types of stressors.
The Body Mind Awareness Program, an approach based 
on the Mindfulness-Based Stress Reduction model,21,22 
was initiated as a pilot project in 1997 and, given its initial 
success, was subsequently incorporated into the stream of Journal of Multidisciplinary Healthcare 2009:2 55
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interventions and treatment options available to individuals at 
the NSEHC. The Body Mind Awareness Program (BMAP) 
at the NSEHC follows the guidelines of the original MBSR 
program developed by Jon Kabat-Zinn.21 Illness is a major 
stressor, and how one copes with stress has consequences for 
health outcomes. Results from other trials using the MBSR 
approach have shown that it is effective in reducing anxiety, 
depression, pain, and psychological symptoms associated with 
illness.22–29
Evaluations based on anecdotal reports collected at the 
end of each BMAP program have revealed the beneﬁ  cial 
nature of this technique as applied to individuals seeking 
treatment at the NSEHC. Patients report feeling less anxious, 
less depressed, use less pain medication, experience better 
sleep, and achieve a better quality of life. A controlled study 
was thus undertaken to quantify these narratives and iden-
tify the type and extent of changes in patients undergoing 
intervention versus wait-list controls using the Symptoms 
Checklist Inventory (SCL-90R).30
Methods
Study participants
The objective of the study was to determine the impact and 
extent of changes in women diagnosed with MCS, CFS, 
and FM following the BMAP intervention when compared 
to a group of individuals that were waiting to be seen at 
the NSEHC. Participants for the intervention group were 
selected from women who received a referral to BMAP 
from a physician at the NSEHC. The intervention group in 
the study continued to receive the usual care management 
that was essential to manage their illness. The control group 
consisted of the ﬁ  rst 50 women from the wait list group who 
consented to participate in the study.
Study design
The study compared the results of a 10-week intervention 
group that underwent training in the MBAP to a control 
group that was comprised of women waitlisted to be seen as 
patients at the NSEHC. The participants were screened for the 
following exclusionary criteria: subjects with major illnesses 
such as cancer; and subjects with an untreated psychiatric 
disorder and that might be negatively affected by the program 
or that might affect the group process. Medication type and 
usage were assessed for all participants during the study.
There were no people excluded on the basis of the outlined 
criteria for this study. Men who participated in the BMAP 
intervention were excluded from the study sample since 
women were a fair representation of the patient population.13 
Following the receipt of informed consent, an intervention 
group undertook 10-week training in mindfulness-based stress 
reduction of 2.5 hours each week, in addition to committing to 
a daily home practice. The study received ethical approval by 
the Capital District Health Authority Ethics Committee.
Body mind awareness program – 
mindfulness-based stress reduction model
The BMAP typically consists of 10 weekly group meetings, 
each one lasting approximately 2.5 hours. The facilitator is 
trained in MBSR through the Omega Institute, Rhinebeck, 
New York with 12 years experience in facilitating the BMAP 
intervention. Each session provides an opportunity for partic-
ipants to share their experiences of the week of mindfulness 
practice of the body scan, sitting meditation, or mindfulness 
yoga. Patients learn about the psychophysiology of stress and 
emotions. One session is reserved as a silent “retreat” of six 
hours at week 8 of the program. Commitment to the home-
work exercises which involve the practice of mindfulness 
both formally (sitting meditation, yoga, and body scan) and 
informally (eating, cooking, driving, and other day-to-day 
activities) is an essential component of the program. With 
the guidance and support from the instructor, participants 
begin to generalize what they learn in class and in daily 
home practice towards the management of their daily lives 
and their illness challenges in particular.
Participants are provided with compact discs that guide 
them through the formal mindfulness practices: yoga, mind-
fulness meditation practices, and the body scan. In addition, 
as the practices develop, patients are introduced to the con-
cept that thoughts are not facts and that one can develop the 
ability to respond to stressors, rather than react to them. The 
goal is to help participants become more aware of thoughts, 
feelings, and sensations and their inter-related connections.
To ensure the consistent application of the principles 
learned, a workbook is provided for each person to follow 
throughout the intervention. With the commitment to 
repeated mindfulness practices, participants begin to develop 
the ability to step out of habitual reactive patterns or negative-
thinking patterns that might otherwise escalate to a cycle 
of stress reactivity and a heightened arousal state during 
stressful life-moments.
Outcome measures and statistical 
analysis
The intervention group answered the SCL-90R pre- and 
post-intervention (before commencement of BMAP inter-
vention and at the end of 10-week intervention) and at a Journal of Multidisciplinary Healthcare 2009:2 56
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three-month follow-up. SCL-90R was administered to the 
control group at the same time periods. In a clinical evaluation 
conducted at the NSEHC using SCL-90R, Brief Symptoms 
Inventory, McGill Pain Questionnaire and WHOQOL-BREF 
(World Health Organization Quality of Life), SCL-90R was 
identiﬁ  ed as the most compelling outcome for BMAP based 
on the consistency and sensitivity in capturing the changes 
pre and post intervention. Data analysis for this study utilized 
SAS (version 9.1; SAS Institute Inc., Cary, NC, USA), and 
the usual procedures for continuous data (t-test, analysis of 
variance, general linear model [GLM]) and categorical data 
(SAS processes: FREQ, LOGISTIC).
Results
The study included 50 women in the intervention group and 
26 women in the control group. Mean age of participants 
in the intervention group was 46.5 (standard deviation 
[SD] = 9.3, range = 35–64) and in the control group was 
44.5 (SD = 8.5, range = 32–60).
Approximately 16% of the total recruited participants 
dropped out of the intervention group for reasons such as work 
commitments, deterioration in health, or family reasons. In 
the control group, 26 of the 50 wait-listed patients approached 
for participation completed the questionnaires at the set time 
periods (pre-, post-, and follow up) and became a part of the 
study sample. 76% of the intervention group had a diagnosis 
of MCS in combination with FM and CFS, 15% had a diag-
nosis of FM, and the remaining participants had a diagnosis of 
CFS. The wait-list control group had not received a diagnosis 
from the NSEHC’s physician at the time of recruitment. The 
group comprising all women, was selected because they had 
a referral to be seen at the NSEHC.
Independent sample t-tests were used to compare SCL90-R 
Global Severity Index (GSI) and subscale scores between the 
wait-list control and MBSR treatment group at baseline, post-
treatment (10 weeks), and three-month follow-up. Results 
are summarized in Table 1. The two groups were equal on 
GSI scores at baseline, with the MBSR treatment group 
having signiﬁ  cantly lower scores than the control group at 
post-treatment (t[74] = 2.35, p  0.05), and at follow-up 
(t[74] = 3.86, p  0.001). All subscale scores except for the 
somatization subscale were equal at baseline between the two 
groups. Five of nine subscales were signiﬁ  cantly lower for the 
MBSR group following treatment, and eight of nine subscales 
were signiﬁ  cantly lower for the MBSR group at three-month 
follow-up as summarized in Table 1. Paired samples tests 
were used to compare changes in SCL90-R GSI and subscale 
scores from baseline to post-treatment and from post-treatment 
to three-month follow-up, within each group. The long-term 
effects of treatment were examined using a GLM repeated-
measures procedure for the GSI, as well as the somatization, 
anxiety, and depression subscales, with treatment group as the 
between-subject variable and time (baseline, post-treatment, 
and follow-up) as the within-subject variable. A signiﬁ  cant 
group × time interaction would indicate the presence of a 
treatment effect. A signiﬁ  cant group × time interaction was 
found for GSI (F[2,73] = 6.83, p  0.01), as well as the depres-
sion (F[2,73] = 7.88, p  0.01) and anxiety (F[2,73] = 3.15, 
p  0.05) subscales, but no signiﬁ  cant interaction was found for 
the somatization subscale (F[2,73] = 0.773, not signiﬁ  cant).
Discussion
The broader objective of the study was to determine the 
efﬁ  cacy of a MBSR approach (BMAP) in individuals with 
conditions such as MCS, CFS, and FM. Results from other 
trials using the MBSR approach have shown reductions 
in anxiety, depression, pain, and psychological symptoms 
associated with illness. Clinical evaluations conducted at the 
NSEHC have shown that BMAP is able to alleviate some of 
the stressful symptoms of MCS, CFS, and FM, and promotes 
a sense of well being in our patient population. Also, our 
research has shown individuals with MCS exist in a state of 
hypervigilance19 and BMAP is targeted towards altering this 
state of arousal. This study was an attempt to quantify the 
positive changes and beneﬁ  ts reported by NSEHC patients 
upon completion of the BMAP as measured in our clinical 
evaluations, and compare the outcome with women that were 
waiting to receive intervention, wait-list controls.
The type and the extent of changes measured in the inter-
vention group were consistent with the reports measured in 
clinical evaluations between 1998 and 2003 conducted at the 
NSEHC. The results show signiﬁ  cant improvements in the 
intervention group in the GSI scores of the SCL-90R at pre- 
to post- and pre-intervention to follow-up when compared 
to the control group. While the scores for the control group 
stayed the same at pre-, post- and follow-up intervention, the 
intervention group showed signiﬁ  cant improvements post-
intervention and at three-month follow-up. Some of these 
changes are signiﬁ  cant ﬁ  ndings for this patient population. 
However, it would be too simplistic to draw a linear causal 
relationship between environmental illness and psychological 
responses. The sheer complexity of the relationship between 
being human and responding to the physical environment 
may heighten or accentuate the inﬂ  uence of a variety of 
stressors. While it is hard to draw a linear relationship, it is 
possible to delve into some thoughts around the signiﬁ  cance Journal of Multidisciplinary Healthcare 2009:2 57
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Table 1 Mean (SD) SCL-90R scores and p-values within groups by time (pre- to post-, and post- to follow-up)
Pre- Post- Pre- Post-
SCL-90R BMAP: BMAP: BMAP: Post FUP Con: Con: Con: Post FUP 
Scale Pre Post FUP t-test t-test Pre Post FUP t-test t-test
Mean Mean Mean p value p value Mean Mean Mean p value p value
(SD) (SD) (SD) (SD) (SD) (SD)
Somatization 13.30 10.30 8.50 0.001 0.01 19.92 17.92 17.31 0.29 0.72
(7.47) (5.93) (6.14) (10.38) (10.11) (8.87)
O–C 14.66 10.72 8.32 0.001 0.001 13.77 12.31 13.38 0.5 0.47
(8.97) (5.87) (4.71) (10.34) (11.03) (9.27)
I-S 7.70 5.14 4.26 0.001 0.01 7.96 6.73 7.58 0.46 0.56
(5.57) (3.49) (3.37) (8.88) (8.05) (9.46)
Depression 15.42 9.36 7.78 0.001 0.01 14.73 15.23 15.53 0.82 0.89
(9.19) (5.82) (5.34) (11.32) (12.36) (11.86)
Anxiety 8.48 6.26 4.46 0.05 0.05 8.04 8.62 7.04 0.66 0.23
(6.13) (5.62) (3.07) (7.27) (7.78) (7.20)
Hostility 3.86 3.38 2.64 ns 0.05 2.58 2.27 2.73 0.60 0.30
(3.51) (2.62) (2.24) (2.76) (2.39) (2.86)
Phobic 2.68 1.66 1.40 0.01 ns 3.19 2.96 3.15 0.66 0.57
(3.19) (1.89) (1.56) (4.74) (3.67) (4.39)
Paranoid 5.00 3.16 2.58 0.001 0.05 4.27 4.62 4.77 0.56 0.84
(3.36) (2.48) (2.15) (3.92) (5.11) (4.42)
Psychoticism 4.52 2.70 2.36 0.01 ns 5.15 5.54 4.46 0.47 0.91
(4.44) (3.11) (2.53) (5.64) (5.43) (5.19)
GSI 84.10 59.78 47.56 0.001 0.001 88.27 83.77 84.08 0.67 0.97
(44.67) (27.38) (21.59) (62.65) (62.17) (60.09)
Abbreviations: BMAP, body mind awareness program; Con, wait list control group; FUP, follow-up; GSI, global severity index; I-S, interpersonal sensitivity; ns, not signiﬁ  cant; 
O–C, obsessive–compulsive; SCL-90R, symptoms checklist inventory; SD, standard deviation.
of these changes based on the anecdotal reports from our 
clinical evaluations and the results using SCL-90R from 
this study.
Post-intervention improvements were observed in the 
following SCL-90R subscales: somatization, depression, 
phobic anxiety, and paranoid ideation. The stressor of 
phobic anxiety of the environmental stressors, perceived as 
threatening can be disproportionate to the offending trigger. 
This trend showed statistical improvement in the participants 
of the BMAP at post-program to a three-month follow-up. 
As is the case of a large proportion of the environmentally 
sensitive patients at the NSEHC, they receive a referral to the 
NSEHC following a signiﬁ  cant investment of time, energy, 
and resources in the health care system to “ﬁ  nd an answer” 
to their problems. Often they are met with disdain, disbelief, 
ridicule, and a referral to psychiatry, which is to say their 
illness is “all in their heads” further complicating a poorly 
understood and difﬁ  cult-to-treat collection of conditions. 
Disordered thinking traits also changed post-intervention 
as seen in the positive changes of the somatization subscale Journal of Multidisciplinary Healthcare 2009:2 58
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of the SCL-90R. The characteristics of projective thought 
of feeling unsafe in ones’ personal environment, hostility 
towards health care and insurance providers, suspiciousness, 
grandiosity, fear of loss of autonomy and delusions were 
shown to improve. In the BMAP, a central component of the 
training is recognizing thoughts as mental events and not as 
absolute truths or facts. Participants practice becoming aware 
of the cascade of habits of mind such as catastrophizing, vic-
timizing, and rumination. Daily practice encourages a broader 
perspective of thoughts and images passing through the mind 
and by turning attention to the breath brings acceptance to 
the present moment without judgment of pleasant, unpleasant 
or neutral feelings. In this way resiliency to seeing things as 
they are, and gaining some distance and perspective on them 
begin to take hold. This perhaps creates awareness that there 
may be other ways to think about situations, and thus ﬁ  nd 
freedom from the domination of old thought patterns that 
pop up automatically.
At the three-month follow-up, other changes with the 
intervention group that showed statistical signiﬁ  cance were 
traits of obsessive compulsiveness, interpersonal sensitivity, 
anxiety and psychosis. The obsessive nature of thoughts, 
and “safe” behaviors (such as avoidance or isolation) was 
greatly improved with the BMAP intervention; feelings 
of inferiority or inadequacy because of an unexplainable 
health condition, self-doubt about their health and ability 
to regain healthy functioning, and self-deprecation are also 
characteristic features of depressed mood states. The nature 
of practicing daily homework and attending weekly classes in 
a group format provided a forum for consistency, discipline, 
self-responsibility, camaraderie and trust, and an increased 
sense of self mastery which helped to mitigate the negative 
side-effects of negative mood states.
A number of factors modulate the impact of health and 
wellness on an individual: personality factors, anxiety, coping 
skills and the psychological context within which environ-
mental stressors function. The BMAP is a means for such 
individuals to alleviate psychosocial/life stressors that may 
help change the state of arousal, strengthen inner resiliency 
to mitigate the negative effects of stressors associated with 
illness, and develop healthy coping skills for the manage-
ment of their illness.
Limitations
The study was not conducted in a randomized design which 
would have enhanced the quality of the research study. 
However, we considered it unethical for patients to wait to 
receive treatment following a long wait time to receive the 
appropriate referral to receive timely care. Using wait-list 
controls with a non-biased selection process which involved 
using the ﬁ  rst 50 women to provide consent was an efﬁ  cient 
way to obtain a control group for the study. The wait-list 
patients typically waited from 4–6 months to receive treat-
ment at the NSEHC, and hence it was convenient to choose 
this group to measure changes at 0, 10 weeks, and three-
month follow-up time periods. Subscales of the SCL-90R 
that have shown trends of change or getting close to statistical 
signiﬁ  cance might have reached statistical signiﬁ  cance with 
a larger sample size.
Conclusion
The study has shown the importance of a MBSR intervention 
as a complement to the mainstream management strategies 
for patients with MCS, CFS, and FM in improving psy-
chological distress and strengthening mental and physical 
resiliency to disease management. Most importantly, with 
this training format and experiential teaching to embrace 
the present moment, the locus of control31 shifts back to the 
patient as they learn to reconstruct their lives independent 
from external measures such as success, approval and com-
pliancy, and reconnect with the power of choice in their 
lives and control over their circumstances to live happier 
and productive lives.
Disclosure
The authors report no conﬂ  icts of interest in this work.
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